Recommendations for the care of women with epilepsy

Cleveland Clinic Journal of Medicine

Volumn 71, Issue SUPPL. 2, 2004, Pages

  Penovich, Patricia E ^a   Eck, Karen E ^b   Economou, Vasiliki V ^c  

^a MINNESOTA EPILEPSY GROUP   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c Neurological and Epilepsy Consultants   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ANTICONVULSIVE AGENT; CALCITONIN; CALCIUM; ESTROGEN; FOLIC ACID; GLUCOCORTICOID; GONADORELIN AGONIST; HEPARIN; IMMUNOSUPPRESSIVE AGENT; RALOXIFENE; RISEDRONIC ACID; THYROXINE; VITAMIN D; VITAMIN K GROUP;

ANOVULATION; BONE DEVELOPMENT; BREAST FEEDING; CALCIUM INTAKE; CATAMENIAL EPILEPSY; CONGENITAL MALFORMATION; DEPRESSION; DIET SUPPLEMENTATION; EPILEPSY; FEMALE; FEMALE FERTILITY; HUMAN; LONG TERM CARE; MENOPAUSE; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; QUALITY OF LIFE; REVIEW; RISK FACTOR; TERATOGENICITY; VITAMIN SUPPLEMENTATION; GYNECOLOGIC DISEASE; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATION;

ANTICONVULSANTS; DEPRESSIVE DISORDER; EPILEPSY; FEMALE; GENITAL DISEASES, FEMALE; HUMANS; MENOPAUSE; OSTEOPOROSIS; PERINATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 4944224320     PISSN: 08911150     EISSN: 08911150     Source Type: Journal    
DOI: 10.3949/ccjm.71.suppl_2.s49     Document Type: Review

References (24)

1. Carter JD, Attarian HP, Vahle VJ, et al. Distribution of the severity of depressive symptoms and suicidal ideation in a large epilepsy outpatient sample. Poster presented at: annual meeting of the American Epilepsy Society, Philadelphia, Pa; Nov. 30-Dec. 5, 2001.
2. Lambert MV, Robertson MM. Depression in epilepsy: etiology, phenominology and treatment. Epilepsia 1999; 40(suppl 10):S21-S47.
3. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 38:1082-1088.
4. Feely M, Calvert R, Gibson J. Clobaram in catamenial epilepsy: a model for evaluating anticonvulsants. Lancet 1982; 2:71-73.
5. Feely M, Gibson J. Intermittent clobaram for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984; 47:1279-1282.
6. Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology. 1995; 45:1660-1662.
7. Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999; 52:1917-1918.
8. Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995; 36:355-359.
9. Herzog AG. Polycystic ovarian syndrome in women with epilepsy: epileptic or iatrogenic? Ann Neurol 1996; 39:559-560.
10. Morrell MJ, Giudice J, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002; 52:704-711.
11. Schupf N, Ottman R. Likelihood of pregnancy in individuals with idiopathic/cryptogenic epilepsy: social and biologic influences. Epilepsia 1994; 35:750-756.
12. Lobo RA. A disorder without identity: "HCA," "PCO," "PCOD," "PCOS," "SLS". What are we to call it? Fertil Steril 1995; 63:1158-1160.
13. Honein MN, Paulozzi LJ, Matthews TJ, et al. Impact of folic acid fortification of the US food supply on the occurrence of neural tube defects. JAMA 2001; 285:2981-2986.
14. Wilbur K, Ensom MHH. Pharmacokinetic drug interactions between oral contraceptives and second generation anticonvulsants. Clin Pharmacokinet 2000; 38:355-365.
15. Brodie MJ, Schachter SC. Epilepsy. 2nd ed. Oxford, UK: Health Press Limited; 2001.
16. Shorvon S, Dreifuss F, Fish F, Thomas D, eds. The Treatment of Epilepsy. Cambridge, UK: Blackwell Science, Inc.; 1996.
17. Yerby M, El-Sayed Y. Pregnancy risks for the woman with epilepsy. In: Morrell MJ, Flynn K, eds. Women With Epilepsy: A Handbook of Health and Treatment Issues. New York, N.Y.: Cambridge University Press; 2003:203-214.
18. Ramos RM, Cantrell DC, Cunningham DC, et al. Effects of partial seizures on the infants of women with epilepsy. Epilepsia 1997; 38(suppl 8):230.
19. Lamotrigine Pregnancy Registry: Interim Report. July 2003. Research Triangle Park, N.C.: GlaxoSmithKline.
20. Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications (chapter 88). In: Wyllie E, ed. The Treatment of Epilepsy: Principles and Practices. 3rd ed. Philadelphia, Pa.: Lippincott Williams & Wilkins; 2001:1215-1225.
21. Abassi F, Krumholz A, Kittner SL, et al. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999; 40:205-210.
22. Pack AM, Morrell MJ, Randall A, et al. Markers of general bone function, bone formation and bone resorption in women with epilepsy on antiepileptic drug monotherapy. Neurology 2003; 60(suppl 1):A432. Abstract.
23. Kondo R, Tokinata N, Suzuki A, et al. Altered pharmacokinetics and metabolism of valproate after replacement of conventional valproate with the slow-release formulation in epileptic patients. Pharmacol Toxicol 2002; 90:135-138.
24. McClung MR. The menopause and HRT. Prevention and management of osteoporosis. Best Pract Res Clin Endocrinol Metab 2003; 17:53-71.